Improving Surgical Outcomes

Slides:

Advertisements

Similar presentations

Bridion® in Clinical Practice: Case Study

Advertisements

NEUROMUSCULAR BLOCKADE REVERSAL PRACTICE

Matthias Eikermann, M.D., PhD

Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications Source:Anesthesiology.

Neuromuscular monitoring By Dr. Ahmed Mostafa Assist. prof. of anesthesia and I.C.U.

Practice Guidelines for the Prevention, Detection, and Management of Respiratory Depression Associated with Neuraxial Opioid Administration Troy Tada,

Conscious Sedation.

Inguinal Hernia of Premature Infants

Neurology Chapter of IAP

Intrathecal Morphine Usage in Hepatobiliary Surgery Dr David Cosgrave Dr Era Soukhin Dr Anand Puttapa Dr Niamh Conlon.

Impact of Care Bundle Approach in Prevention of Surgical Site Infection in Abdominoplasty Patients Mabrouk AR*, Helal HA*, El-Mekkawy SF* and Abdallah.

Neuromuscular Blockers

Manufacturer: Merck FDA Approval Date: December 15, 2015

NAP5 The 5th National Audit Project ■ ■ ■ ■ ■ NAP5 The 5th National Audit Project ■ ■ ■ ■ ■ NAP5 The 5th National Audit Project ■ ■ ■ ■ ■ Neuromuscular.

Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.

Sensitivity Analyses Intraoperative neuromuscular blocking agent administration and hospital readmission Sub-cohort Frequency of readmitted patients (percent.

CON 280: Source Selection and the Administration of Service Contracts

Optimal Management of Spinal Muscular Atrophy

This program will include a discussion of agents not approved by the FDA for use in the US

Oral Anticoagulants and Reversal Agents

This program will include a discussion of off-label treatment not approved by the FDA for use in the United States.

Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents.

NOACs In Long-term VTE Treatment: A State Of The Art Review

Program Goals. The Importance of Neuromuscular Blockade Reversal for Enhancing Recovery of Surgical Patients.

Awareness During Anesthesia

Does One Size Fit All in Obesity Management?

NOACs in Clinical Practice: Are They All the Same?

Appropriate Stroke Prevention Strategies in Atrial Fibrillation

Residual Paralysis Is More Common Than You Think

Misconceptions in Ambulatory Surgery

Reducing Postoperative Ileus

A New Era for NOACs:.

Effective Management of Complicated Urinary Tract Infections

How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients

Strategies for Assessing and Preserving Function in ALS

Impact of the Introduction of Sugammadex

Oral Anticoagulants in AFa,b A Brief History.

Improving Surgical Patient Safety

Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.

PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma.

Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.

Improved postoperative oxygenation after antagonism of moderate neuromuscular block with sugammadex versus neostigmine after extubation in ‘blinded’ conditions

Are We Closer to Personalized Medicine in MS?

Statins and Glucose Metabolism: Are All Agents Alike?

A Journal Club on Lipid Management:

Oral Anticoagulation in AF

Minimal Residual Disease in CLL

EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.

Updates on Neuromuscular Blockage monitoring

Management of Systematic Lupus Erythematosus

Repeat dosing of rocuronium 1

Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.

Aspirin and Cardioprevention in 2018

Treatment-Resistant Schizophrenia

Expert Perspectives on Postoperative Ileus

What we already know Most studies have shown that NMBAs are the commonest cause (44-60%)of perioperative anaphylaxis Previous studies have been hampered.

Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis M.H. Bruintjes, E.V.

P.J. Schuller, S. Newell, P.A. Strickland, J.J. Barry

How to Manage ISRs That Occur With Injectable Agents in Psoriasis

Clonidine in Patients Having Noncardiac Surgery

Etiology and Incidence Pathophysiology Hemophilia is due to a defect in thrombin generation on the platelet surface.

Incorporating Prostacyclins Into Practice

Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.

Factor Xa Inhibitors in Coronary Artery Disease

What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.

Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers G Cammu,

Minimal Residual Disease and Hematologic Malignancies

Questions/comments to EVS (CN)

Postoperative residual neuromuscular block: a survey of management

PCSK9 Inhibitors and Real-World Evidence

Presentation transcript:

Improving Surgical Outcomes

Program Objective

Strategies for Minimizing Risk of Postoperative Residual NMB

EMG

Mechanomyography

Kinemyography

AMG

Benefits of EMG Monitoring

Case Example: PNS vs AMG

Assessment at End of Operation

Visual and Tactile Detection of Fade

Assessment After 10 Minutes

Assessment After Reversal Agent Is Administered

Potential CREs With Residual NMB

Incidence of CREs

Administration of Anticholinesterase NMB Reversal Agents

Consensus Statement on Perioperative Use of Neuromuscular Monitoring

Benefit of Easy-to-Use Objective Monitors

Clinical Effect of Objective Monitoring

Neostigmine

Dosing of Neostigmine

Time to NMB Reversal With Neostigmine

Potential Respiratory Complications With Inappropriate Neostigmine Administration

Sugammadex

NMB Reversal With Sugammadex vs Neostigmine

Dosing of Sugammadex

Conclusions

Abbreviations